Matches in Wikidata for { <http://www.wikidata.org/entity/Q65469896> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q65469896 description "clinical trial" @default.
- Q65469896 description "ensayu clínicu" @default.
- Q65469896 description "klinisch onderzoek" @default.
- Q65469896 description "клінічне випробування" @default.
- Q65469896 description "կլինիկական փորձարկում" @default.
- Q65469896 name "Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma" @default.
- Q65469896 name "Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma" @default.
- Q65469896 type Item @default.
- Q65469896 label "Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma" @default.
- Q65469896 label "Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma" @default.
- Q65469896 prefLabel "Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma" @default.
- Q65469896 prefLabel "Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma" @default.
- Q65469896 P1050 Q65469896-CFEB99C1-D250-48B8-91C5-18D550AEC806 @default.
- Q65469896 P1132 Q65469896-2528EB77-11E9-4087-8A40-F92712BC2386 @default.
- Q65469896 P1476 Q65469896-7E9D30A4-662D-4CE0-AD61-36DD7A875632 @default.
- Q65469896 P17 Q65469896-E236DC16-538D-4208-9903-00BCBC75B686 @default.
- Q65469896 P2899 Q65469896-5EFD42F7-CA37-4B81-86CC-8969D6A94478 @default.
- Q65469896 P3098 Q65469896-B29C8440-1C54-4973-A8FB-1D60C6A2E251 @default.
- Q65469896 P31 Q65469896-C38FDAD4-E204-4F47-8FDF-8986C2631F96 @default.
- Q65469896 P4844 Q65469896-31983CEF-E819-4DD3-B5BF-0661FEC5482C @default.
- Q65469896 P4844 Q65469896-71C9D7B8-4A78-4531-9E98-83EE36663D61 @default.
- Q65469896 P580 Q65469896-DE50DA5F-EE40-4F77-ACEF-62D8B3681616 @default.
- Q65469896 P582 Q65469896-9B14BA59-0A92-4CAB-BE2E-A74764727C3F @default.
- Q65469896 P6099 Q65469896-F817DDD2-1F7F-4531-96A7-B85B546A69F3 @default.
- Q65469896 P6153 Q65469896-2B6F3821-1ADA-4E4F-8AF8-270D59FFD297 @default.
- Q65469896 P6153 Q65469896-3CA7B87E-55BB-402D-A1DC-D393637D9E66 @default.
- Q65469896 P6153 Q65469896-B3F72F97-4D68-4B98-A9B5-307823E23942 @default.
- Q65469896 P6153 Q65469896-C9DF6808-842B-44DD-8B37-F3E3D933061D @default.
- Q65469896 P6153 Q65469896-EAF1586D-EC4F-49DC-99E3-61B4C8CE7651 @default.
- Q65469896 P767 Q65469896-89C8728D-5564-4F48-8A17-BF789D8B3D48 @default.
- Q65469896 P767 Q65469896-C3B080B3-65A8-45C2-895B-4B9802B257C6 @default.
- Q65469896 P8363 Q65469896-07872D9E-5718-4068-923D-0A2DC96A44C9 @default.
- Q65469896 P1050 Q356033 @default.
- Q65469896 P1132 "+111" @default.
- Q65469896 P1476 "A Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Patients With Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma" @default.
- Q65469896 P17 Q30 @default.
- Q65469896 P2899 "+18" @default.
- Q65469896 P3098 "NCT00515411" @default.
- Q65469896 P31 Q30612 @default.
- Q65469896 P4844 Q238512 @default.
- Q65469896 P4844 Q412415 @default.
- Q65469896 P580 "2006-10-23T00:00:00Z" @default.
- Q65469896 P582 "2018-10-26T00:00:00Z" @default.
- Q65469896 P6099 Q42824440 @default.
- Q65469896 P6153 Q1047060 @default.
- Q65469896 P6153 Q49115 @default.
- Q65469896 P6153 Q6672700 @default.
- Q65469896 P6153 Q6806307 @default.
- Q65469896 P6153 Q7191520 @default.
- Q65469896 P767 Q6672700 @default.
- Q65469896 P767 Q6806307 @default.
- Q65469896 P8363 Q78089383 @default.